Dr. Robert J. Pace, MD
Neurology (Neurology Physician)
819 N Shiawassee St Ste 110
Owosso, MI 48867
Who else practices at this address →
Shiawassee County is a federal mental health shortage area. About shortage areas
- Medicare participating
At a glance
- Years since graduation
- 18
- In the NPI registry since
- 2008
- Medicare patients seen, 2024
- 151
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2008Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurology Physician primary
MI license 4301092694
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Mymichigan Medical Center Midland Midland, MI
- Memorial Healthcare Owosso, MI
- University of Michigan Health- Sparrow Clinton Saint Johns, MI
Medical groups
- Powerback Rehabilitation LLC (649 clinicians)
- Memorial Hospital (214 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 151
- Services billed
- 1,107
- Patients’ average age
- 61
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 219 | 135 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Gabapentin Other prescribers in Owosso, MI | 325 |
| Dalfampridine Er (dalfampridine) | 322 |
| Baclofen Other prescribers in Owosso, MI | 304 |
| Kesimpta Pen (ofatumumab) | 284 |
| Pregabalin Other prescribers in Owosso, MI | 183 |
| Modafinil Other prescribers in Owosso, MI | 137 |
| Citalopram Hbr (citalopram hydrobromide) Other prescribers in Owosso, MI | 113 |
| Diazepam Other prescribers in Owosso, MI | 107 |
| Duloxetine Hcl Other prescribers in Owosso, MI | 82 |
| Topiramate Other prescribers in Owosso, MI | 81 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 15 companies reported 112 payments worth $71,785 in total to this clinician.
| EMD Serono, Inc. | $48,983 |
|---|---|
| Tg Therapeutics, Inc. | $13,583 |
| Biogen, Inc. | $6,299 |
| Novartis Pharmaceuticals Corporation | $2,310 |
| AbbVie Inc. | $162 |
| Genentech, Inc. | $120 |
| Celgene Corporation | $76.26 |
| Vanda Pharmaceuticals Inc. | $54.65 |
| Compensation for services other than consulting (speaking, faculty) | $59,778 |
|---|---|
| Travel and Lodging | $6,647 |
| Consulting Fee | $3,007 |
| Food and Beverage | $2,298 |
| Education | $55.00 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| EMD Serono, Inc. May 23, 2025 | Compensation for services other than consulting (speaking, faculty) Mavenclad · Neurology Company’s descriptionSpeaker Training (Fee For Service) | $8,970 |
| EMD Serono, Inc. Nov 13, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionSpeaking Services (Fee For Service) | $6,555 |
| EMD Serono, Inc. Jun 10, 2025 | Compensation for services other than consulting (speaking, faculty) Mavenclad · Neurology Company’s descriptionSpeaking Services (Fee For Service) | $5,175 |
| EMD Serono, Inc. Jul 9, 2025 | Compensation for services other than consulting (speaking, faculty) Mavenclad · Neurology Company’s descriptionSpeaking Services (Fee For Service) | $5,175 |
| EMD Serono, Inc. Mar 28, 2025 | Compensation for services other than consulting (speaking, faculty) Mavenclad · Neurology Company’s descriptionSpeaking Services (Fee For Service) | $5,175 |
| Tg Therapeutics, Inc. Apr 26, 2025 | Compensation for services other than consulting (speaking, faculty) BRIUMVI · Immunology | $4,185 |
| EMD Serono, Inc. Aug 14, 2025 | Compensation for services other than consulting (speaking, faculty) Mavenclad · Neurology Company’s descriptionSpeaking Services (Fee For Service) | $3,795 |
| EMD Serono, Inc. Nov 17, 2025 | Compensation for services other than consulting (speaking, faculty) Mavenclad · Neurology Company’s descriptionSpeaking Services (Fee For Service) | $3,795 |
| Biogen, Inc. Feb 12, 2025 | Compensation for services other than consulting (speaking, faculty) VUMERITY · Neurology | $3,766 |
| Tg Therapeutics, Inc. Apr 8, 2025 | Compensation for services other than consulting (speaking, faculty) BRIUMVI · Immunology | $3,713 |
All 31 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| EMD Serono, Inc. Dec 30, 2025 | Compensation for services other than consulting (speaking, faculty) Mavenclad · Neurology Company’s descriptionSpeaker Training (Fee For Service) | $690 |
| Tg Therapeutics, Inc. Nov 20, 2025 | Compensation for services other than consulting (speaking, faculty) BRIUMVI · Immunology | $465 |
| EMD Serono, Inc. Nov 17, 2025 | Compensation for services other than consulting (speaking, faculty) Mavenclad · Neurology Company’s descriptionSpeaking Services (Fee For Service) | $3,795 |
| EMD Serono, Inc. Nov 13, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionSpeaking Services (Fee For Service) | $6,555 |
| EMD Serono, Inc. Oct 29, 2025 | Travel and Lodging travel to Appleton, WI Company’s descriptionSpeaking Services (Transportation) | $1,602 |
| EMD Serono, Inc. Oct 29, 2025 | Travel and Lodging travel to Appleton, WI Company’s descriptionSpeaking Services (Transportation) | $591 |
| EMD Serono, Inc. Oct 29, 2025 | Travel and Lodging travel to Appleton, WI Company’s descriptionSpeaking Services (Transportation) | $65.00 |
| Biogen, Inc. Sep 16, 2025 | Compensation for services other than consulting (speaking, faculty) TYSABRI · Neurology | $1,614 |
| Tg Therapeutics, Inc. Sep 11, 2025 | Compensation for services other than consulting (speaking, faculty) BRIUMVI · Immunology | $233 |
| EMD Serono, Inc. Aug 14, 2025 | Compensation for services other than consulting (speaking, faculty) Mavenclad · Neurology Company’s descriptionSpeaking Services (Fee For Service) | $3,795 |
| Biogen, Inc. Aug 11, 2025 | Consulting Fee TYSABRI · Neurology | $269 |
| Biogen, Inc. Aug 4, 2025 | Consulting Fee VUMERITY · Neurology | $538 |
| EMD Serono, Inc. Jul 9, 2025 | Compensation for services other than consulting (speaking, faculty) Mavenclad · Neurology Company’s descriptionSpeaking Services (Fee For Service) | $5,175 |
| EMD Serono, Inc. Jul 9, 2025 | Compensation for services other than consulting (speaking, faculty) Mavenclad · Neurology Company’s descriptionSpeaking Services (Fee For Service) | $2,415 |
| EMD Serono, Inc. Jun 13, 2025 | Travel and Lodging Mavenclad · Neurology · travel to Traverse City, MI Company’s descriptionSpeaking Services (Transportation) | $2,567 |
| Novartis Pharmaceuticals Corporation Jun 13, 2025 | Consulting Fee KESIMPTA · Neurology | $2,200 |
| EMD Serono, Inc. Jun 13, 2025 | Travel and Lodging Mavenclad · Neurology · travel to Traverse City, MI Company’s descriptionSpeaking Services (Transportation) | $532 |
| EMD Serono, Inc. Jun 13, 2025 | Travel and Lodging Mavenclad · Neurology · travel to Traverse City, MI Company’s descriptionSpeaking Services (Lodging) | $253 |
| Tg Therapeutics, Inc. Jun 11, 2025 | Compensation for services other than consulting (speaking, faculty) BRIUMVI · Immunology | $3,713 |
| EMD Serono, Inc. Jun 10, 2025 | Compensation for services other than consulting (speaking, faculty) Mavenclad · Neurology Company’s descriptionSpeaking Services (Fee For Service) | $5,175 |
| EMD Serono, Inc. Jun 6, 2025 | Travel and Lodging Mavenclad · Neurology · travel to Flint, MI Company’s descriptionSpeaking Services (Transportation) | $70.00 |
| EMD Serono, Inc. May 23, 2025 | Compensation for services other than consulting (speaking, faculty) Mavenclad · Neurology Company’s descriptionSpeaker Training (Fee For Service) | $8,970 |
| Tg Therapeutics, Inc. Apr 26, 2025 | Compensation for services other than consulting (speaking, faculty) BRIUMVI · Immunology | $4,185 |
| Tg Therapeutics, Inc. Apr 25, 2025 | Travel and Lodging BRIUMVI · Immunology · travel to Dallas, TX · in-kind | $408 |
| Tg Therapeutics, Inc. Apr 25, 2025 | Travel and Lodging BRIUMVI · Immunology · travel to Dallas, TX · in-kind | $316 |
| Tg Therapeutics, Inc. Apr 8, 2025 | Compensation for services other than consulting (speaking, faculty) BRIUMVI · Immunology | $3,713 |
| EMD Serono, Inc. Mar 28, 2025 | Compensation for services other than consulting (speaking, faculty) Mavenclad · Neurology Company’s descriptionSpeaking Services (Fee For Service) | $5,175 |
| EMD Serono, Inc. Mar 28, 2025 | Travel and Lodging travel to Nashville, TN Company’s descriptionSpeaking Services (Lodging) | $244 |
| Biogen, Inc. Feb 12, 2025 | Compensation for services other than consulting (speaking, faculty) VUMERITY · Neurology | $3,766 |
| EMD Serono, Inc. Feb 10, 2025 | Education in-kind Company’s descriptionReprints | $55.00 |
| EMD Serono, Inc. Feb 5, 2025 | Compensation for services other than consulting (speaking, faculty) Mavenclad · Neurology Company’s descriptionSpeaker Training (Fee For Service) | $345 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 6 industry-funded studies in 2025, from 3 companies. The companies reported $101,607 in research payments for these studies, mostly to the institutions running them.
- A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.
Genzyme Corporation · Active, not recruiting · NCT06372145 - Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis
Genzyme Corporation · Active, not recruiting · NCT06141473 - Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis
Genzyme Corporation · Active, not recruiting · NCT06141486 - A Randomized, Open-label, Parallel-group, Non-inferiority Study Comparing Efficacy, Safety, and Tolerability of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis, F…
Novartis Pharmaceuticals Corporation - A Randomized, Double-blind, Double-dummy, Parallel-group Study, Comparing the Efficacy and Safety of Remibrutinib Versus Teriflunomide in Participants With Relapsing Multiple Sclerosis, Followed by Extended Treatment …
Novartis Pharmaceuticals Corporation - Observational evaluation of Effectiveness And Patient-Reported outcomes (PROs) in suboptimally controlled patients previously taking oral or infusion disease-modifying drugs (DMDs) for relapsing forms of multiple scle…
EMD Serono, Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.